nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—SLC6A4—Alzheimer's disease	0.164	0.405	CbGaD
Trazodone—HTR2A—Alzheimer's disease	0.126	0.311	CbGaD
Trazodone—HTR2A—Donepezil—Alzheimer's disease	0.12	0.388	CbGbCtD
Trazodone—CYP2D6—Alzheimer's disease	0.115	0.284	CbGaD
Trazodone—CYP2D6—Rivastigmine—Alzheimer's disease	0.0501	0.162	CbGbCtD
Trazodone—CYP2D6—Donepezil—Alzheimer's disease	0.04	0.129	CbGbCtD
Trazodone—CYP3A4—Rivastigmine—Alzheimer's disease	0.0318	0.103	CbGbCtD
Trazodone—CYP2D6—Galantamine—Alzheimer's disease	0.0258	0.0832	CbGbCtD
Trazodone—CYP3A4—Donepezil—Alzheimer's disease	0.0255	0.0821	CbGbCtD
Trazodone—CYP3A4—Galantamine—Alzheimer's disease	0.0164	0.0529	CbGbCtD
Trazodone—HTR2C—choroid plexus—Alzheimer's disease	0.0106	0.199	CbGeAlD
Trazodone—HTR2A—choroid plexus—Alzheimer's disease	0.00532	0.0998	CbGeAlD
Trazodone—HTR2A—locus ceruleus—Alzheimer's disease	0.00329	0.0617	CbGeAlD
Trazodone—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00311	0.0583	CbGeAlD
Trazodone—HTR2A—cerebellar cortex—Alzheimer's disease	0.00268	0.0503	CbGeAlD
Trazodone—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00262	0.0491	CbGeAlD
Trazodone—HTR2A—telencephalic ventricle—Alzheimer's disease	0.00156	0.0292	CbGeAlD
Trazodone—HTR2C—forebrain—Alzheimer's disease	0.000812	0.0152	CbGeAlD
Trazodone—HTR2A—blood vessel—Alzheimer's disease	0.000772	0.0145	CbGeAlD
Trazodone—SLC6A4—forebrain—Alzheimer's disease	0.00077	0.0144	CbGeAlD
Trazodone—HTR2B—forebrain—Alzheimer's disease	0.000763	0.0143	CbGeAlD
Trazodone—HTR2C—telencephalon—Alzheimer's disease	0.000747	0.014	CbGeAlD
Trazodone—SLC6A4—telencephalon—Alzheimer's disease	0.000708	0.0133	CbGeAlD
Trazodone—HTR2B—telencephalon—Alzheimer's disease	0.000701	0.0132	CbGeAlD
Trazodone—HTR1A—forebrain—Alzheimer's disease	0.000683	0.0128	CbGeAlD
Trazodone—ADRA1A—forebrain—Alzheimer's disease	0.00063	0.0118	CbGeAlD
Trazodone—HTR1A—telencephalon—Alzheimer's disease	0.000628	0.0118	CbGeAlD
Trazodone—ADRA1A—telencephalon—Alzheimer's disease	0.000579	0.0109	CbGeAlD
Trazodone—ABCB1—blood vessel—Alzheimer's disease	0.000506	0.00949	CbGeAlD
Trazodone—ORM1—nervous system—Alzheimer's disease	0.00049	0.0092	CbGeAlD
Trazodone—HRH1—forebrain—Alzheimer's disease	0.000488	0.00915	CbGeAlD
Trazodone—ADRA2A—forebrain—Alzheimer's disease	0.000479	0.00898	CbGeAlD
Trazodone—ORM1—central nervous system—Alzheimer's disease	0.000472	0.00885	CbGeAlD
Trazodone—HTR2A—embryo—Alzheimer's disease	0.00046	0.00864	CbGeAlD
Trazodone—HRH1—telencephalon—Alzheimer's disease	0.000448	0.00841	CbGeAlD
Trazodone—HTR2C—nervous system—Alzheimer's disease	0.000441	0.00827	CbGeAlD
Trazodone—ADRA2A—telencephalon—Alzheimer's disease	0.00044	0.00826	CbGeAlD
Trazodone—HTR2C—central nervous system—Alzheimer's disease	0.000424	0.00796	CbGeAlD
Trazodone—SLC6A4—nervous system—Alzheimer's disease	0.000418	0.00784	CbGeAlD
Trazodone—HTR2B—nervous system—Alzheimer's disease	0.000414	0.00776	CbGeAlD
Trazodone—HTR2A—forebrain—Alzheimer's disease	0.000407	0.00764	CbGeAlD
Trazodone—SLC6A4—central nervous system—Alzheimer's disease	0.000402	0.00754	CbGeAlD
Trazodone—HTR2B—central nervous system—Alzheimer's disease	0.000399	0.00748	CbGeAlD
Trazodone—HTR2A—telencephalon—Alzheimer's disease	0.000375	0.00702	CbGeAlD
Trazodone—CYP2D6—forebrain—Alzheimer's disease	0.000371	0.00696	CbGeAlD
Trazodone—HTR1A—nervous system—Alzheimer's disease	0.000371	0.00696	CbGeAlD
Trazodone—HTR1A—central nervous system—Alzheimer's disease	0.000357	0.0067	CbGeAlD
Trazodone—HTR1A—cerebellum—Alzheimer's disease	0.000349	0.00655	CbGeAlD
Trazodone—Vilazodone—SLC6A4—Alzheimer's disease	0.000344	0.0679	CrCbGaD
Trazodone—ADRA1A—nervous system—Alzheimer's disease	0.000342	0.00641	CbGeAlD
Trazodone—CYP2D6—telencephalon—Alzheimer's disease	0.000341	0.0064	CbGeAlD
Trazodone—Ziprasidone—HTR6—Alzheimer's disease	0.00034	0.0672	CrCbGaD
Trazodone—HTR2C—brain—Alzheimer's disease	0.000337	0.00632	CbGeAlD
Trazodone—ADRA1A—central nervous system—Alzheimer's disease	0.000329	0.00617	CbGeAlD
Trazodone—ADRA1A—cerebellum—Alzheimer's disease	0.000322	0.00604	CbGeAlD
Trazodone—SLC6A4—brain—Alzheimer's disease	0.000319	0.00599	CbGeAlD
Trazodone—HTR2B—brain—Alzheimer's disease	0.000316	0.00593	CbGeAlD
Trazodone—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000306	0.00174	CcSEcCtD
Trazodone—Myocardial infarction—Donepezil—Alzheimer's disease	0.000304	0.00173	CcSEcCtD
Trazodone—Nervousness—Galantamine—Alzheimer's disease	0.000304	0.00173	CcSEcCtD
Trazodone—Back pain—Galantamine—Alzheimer's disease	0.000302	0.00172	CcSEcCtD
Trazodone—Jaundice—Donepezil—Alzheimer's disease	0.000302	0.00172	CcSEcCtD
Trazodone—ABCB1—embryo—Alzheimer's disease	0.000302	0.00566	CbGeAlD
Trazodone—Sweating—Donepezil—Alzheimer's disease	0.000297	0.0017	CcSEcCtD
Trazodone—Haematuria—Donepezil—Alzheimer's disease	0.000296	0.00169	CcSEcCtD
Trazodone—Vision blurred—Galantamine—Alzheimer's disease	0.000295	0.00168	CcSEcCtD
Trazodone—Tremor—Galantamine—Alzheimer's disease	0.000293	0.00167	CcSEcCtD
Trazodone—Pollakiuria—Memantine—Alzheimer's disease	0.000292	0.00166	CcSEcCtD
Trazodone—Erectile dysfunction—Memantine—Alzheimer's disease	0.000291	0.00166	CcSEcCtD
Trazodone—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00029	0.00165	CcSEcCtD
Trazodone—Anaemia—Galantamine—Alzheimer's disease	0.000289	0.00165	CcSEcCtD
Trazodone—Zuclopenthixol—HTR6—Alzheimer's disease	0.000288	0.0568	CrCbGaD
Trazodone—Weight increased—Memantine—Alzheimer's disease	0.000287	0.00164	CcSEcCtD
Trazodone—Agitation—Galantamine—Alzheimer's disease	0.000287	0.00164	CcSEcCtD
Trazodone—Weight decreased—Memantine—Alzheimer's disease	0.000286	0.00163	CcSEcCtD
Trazodone—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000285	0.00163	CcSEcCtD
Trazodone—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000284	0.00162	CcSEcCtD
Trazodone—HTR1A—brain—Alzheimer's disease	0.000284	0.00532	CbGeAlD
Trazodone—Bradycardia—Donepezil—Alzheimer's disease	0.000283	0.00162	CcSEcCtD
Trazodone—Malaise—Galantamine—Alzheimer's disease	0.000282	0.00161	CcSEcCtD
Trazodone—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000282	0.00161	CcSEcCtD
Trazodone—Weight increased—Rivastigmine—Alzheimer's disease	0.000281	0.0016	CcSEcCtD
Trazodone—Vertigo—Galantamine—Alzheimer's disease	0.000281	0.0016	CcSEcCtD
Trazodone—Syncope—Galantamine—Alzheimer's disease	0.00028	0.0016	CcSEcCtD
Trazodone—Weight decreased—Rivastigmine—Alzheimer's disease	0.000279	0.00159	CcSEcCtD
Trazodone—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000278	0.00158	CcSEcCtD
Trazodone—Hallucination—Donepezil—Alzheimer's disease	0.000277	0.00158	CcSEcCtD
Trazodone—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000277	0.00158	CcSEcCtD
Trazodone—Palpitations—Galantamine—Alzheimer's disease	0.000276	0.00158	CcSEcCtD
Trazodone—Myocardial infarction—Memantine—Alzheimer's disease	0.000276	0.00157	CcSEcCtD
Trazodone—Drowsiness—Rivastigmine—Alzheimer's disease	0.000275	0.00157	CcSEcCtD
Trazodone—Loss of consciousness—Galantamine—Alzheimer's disease	0.000275	0.00157	CcSEcCtD
Trazodone—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000271	0.00155	CcSEcCtD
Trazodone—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.00027	0.00154	CcSEcCtD
Trazodone—Hypertension—Galantamine—Alzheimer's disease	0.00027	0.00154	CcSEcCtD
Trazodone—Haematuria—Memantine—Alzheimer's disease	0.000268	0.00153	CcSEcCtD
Trazodone—Visual impairment—Donepezil—Alzheimer's disease	0.000268	0.00153	CcSEcCtD
Trazodone—ABCB1—forebrain—Alzheimer's disease	0.000267	0.00501	CbGeAlD
Trazodone—Arthralgia—Galantamine—Alzheimer's disease	0.000266	0.00152	CcSEcCtD
Trazodone—Chest pain—Galantamine—Alzheimer's disease	0.000266	0.00152	CcSEcCtD
Trazodone—Myalgia—Galantamine—Alzheimer's disease	0.000266	0.00152	CcSEcCtD
Trazodone—Aripiprazole—HTR6—Alzheimer's disease	0.000266	0.0525	CrCbGaD
Trazodone—Anxiety—Galantamine—Alzheimer's disease	0.000265	0.00151	CcSEcCtD
Trazodone—HRH1—nervous system—Alzheimer's disease	0.000265	0.00496	CbGeAlD
Trazodone—Sweating—Rivastigmine—Alzheimer's disease	0.000264	0.00151	CcSEcCtD
Trazodone—Discomfort—Galantamine—Alzheimer's disease	0.000263	0.0015	CcSEcCtD
Trazodone—Haematuria—Rivastigmine—Alzheimer's disease	0.000263	0.0015	CcSEcCtD
Trazodone—ADRA1A—brain—Alzheimer's disease	0.000261	0.0049	CbGeAlD
Trazodone—Dry mouth—Galantamine—Alzheimer's disease	0.00026	0.00148	CcSEcCtD
Trazodone—ADRA2A—nervous system—Alzheimer's disease	0.00026	0.00488	CbGeAlD
Trazodone—Tinnitus—Donepezil—Alzheimer's disease	0.00026	0.00148	CcSEcCtD
Trazodone—Confusional state—Galantamine—Alzheimer's disease	0.000257	0.00147	CcSEcCtD
Trazodone—Bradycardia—Memantine—Alzheimer's disease	0.000257	0.00147	CcSEcCtD
Trazodone—HRH1—central nervous system—Alzheimer's disease	0.000255	0.00478	CbGeAlD
Trazodone—Bradycardia—Rivastigmine—Alzheimer's disease	0.000252	0.00144	CcSEcCtD
Trazodone—Hallucination—Memantine—Alzheimer's disease	0.000251	0.00143	CcSEcCtD
Trazodone—Hypoaesthesia—Memantine—Alzheimer's disease	0.000251	0.00143	CcSEcCtD
Trazodone—Shock—Galantamine—Alzheimer's disease	0.000251	0.00143	CcSEcCtD
Trazodone—ADRA2A—central nervous system—Alzheimer's disease	0.00025	0.00469	CbGeAlD
Trazodone—Chills—Donepezil—Alzheimer's disease	0.00025	0.00142	CcSEcCtD
Trazodone—Tachycardia—Galantamine—Alzheimer's disease	0.000249	0.00142	CcSEcCtD
Trazodone—Arrhythmia—Donepezil—Alzheimer's disease	0.000249	0.00142	CcSEcCtD
Trazodone—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000247	0.00141	CcSEcCtD
Trazodone—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000246	0.0014	CcSEcCtD
Trazodone—Hallucination—Rivastigmine—Alzheimer's disease	0.000246	0.0014	CcSEcCtD
Trazodone—Alopecia—Donepezil—Alzheimer's disease	0.000246	0.0014	CcSEcCtD
Trazodone—ABCB1—telencephalon—Alzheimer's disease	0.000245	0.0046	CbGeAlD
Trazodone—ADRA2A—cerebellum—Alzheimer's disease	0.000245	0.00459	CbGeAlD
Trazodone—Visual impairment—Memantine—Alzheimer's disease	0.000244	0.00139	CcSEcCtD
Trazodone—Anorexia—Galantamine—Alzheimer's disease	0.000243	0.00139	CcSEcCtD
Trazodone—Vilazodone—CYP2D6—Alzheimer's disease	0.000242	0.0477	CrCbGaD
Trazodone—Flatulence—Donepezil—Alzheimer's disease	0.000239	0.00136	CcSEcCtD
Trazodone—Hypotension—Galantamine—Alzheimer's disease	0.000238	0.00136	CcSEcCtD
Trazodone—Visual impairment—Rivastigmine—Alzheimer's disease	0.000238	0.00136	CcSEcCtD
Trazodone—Tension—Donepezil—Alzheimer's disease	0.000238	0.00136	CcSEcCtD
Trazodone—Fluphenazine—CALM1—Alzheimer's disease	0.000238	0.0469	CrCbGaD
Trazodone—Dysgeusia—Donepezil—Alzheimer's disease	0.000237	0.00135	CcSEcCtD
Trazodone—Tinnitus—Memantine—Alzheimer's disease	0.000236	0.00134	CcSEcCtD
Trazodone—Nervousness—Donepezil—Alzheimer's disease	0.000235	0.00134	CcSEcCtD
Trazodone—Flushing—Memantine—Alzheimer's disease	0.000235	0.00134	CcSEcCtD
Trazodone—Back pain—Donepezil—Alzheimer's disease	0.000234	0.00134	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000232	0.00133	CcSEcCtD
Trazodone—Insomnia—Galantamine—Alzheimer's disease	0.000231	0.00132	CcSEcCtD
Trazodone—Tinnitus—Rivastigmine—Alzheimer's disease	0.000231	0.00131	CcSEcCtD
Trazodone—Flushing—Rivastigmine—Alzheimer's disease	0.000229	0.00131	CcSEcCtD
Trazodone—Paraesthesia—Galantamine—Alzheimer's disease	0.000229	0.00131	CcSEcCtD
Trazodone—Vision blurred—Donepezil—Alzheimer's disease	0.000228	0.0013	CcSEcCtD
Trazodone—Tremor—Donepezil—Alzheimer's disease	0.000227	0.00129	CcSEcCtD
Trazodone—Somnolence—Galantamine—Alzheimer's disease	0.000227	0.00129	CcSEcCtD
Trazodone—Chills—Memantine—Alzheimer's disease	0.000227	0.00129	CcSEcCtD
Trazodone—Arrhythmia—Memantine—Alzheimer's disease	0.000226	0.00129	CcSEcCtD
Trazodone—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000225	0.00128	CcSEcCtD
Trazodone—Anaemia—Donepezil—Alzheimer's disease	0.000224	0.00128	CcSEcCtD
Trazodone—Alopecia—Memantine—Alzheimer's disease	0.000223	0.00127	CcSEcCtD
Trazodone—Agitation—Donepezil—Alzheimer's disease	0.000223	0.00127	CcSEcCtD
Trazodone—Chills—Rivastigmine—Alzheimer's disease	0.000222	0.00127	CcSEcCtD
Trazodone—Decreased appetite—Galantamine—Alzheimer's disease	0.000222	0.00127	CcSEcCtD
Trazodone—HTR2A—nervous system—Alzheimer's disease	0.000221	0.00415	CbGeAlD
Trazodone—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000221	0.00126	CcSEcCtD
Trazodone—Fatigue—Galantamine—Alzheimer's disease	0.00022	0.00125	CcSEcCtD
Trazodone—Malaise—Donepezil—Alzheimer's disease	0.000219	0.00125	CcSEcCtD
Trazodone—Alopecia—Rivastigmine—Alzheimer's disease	0.000218	0.00125	CcSEcCtD
Trazodone—Constipation—Galantamine—Alzheimer's disease	0.000218	0.00124	CcSEcCtD
Trazodone—Vertigo—Donepezil—Alzheimer's disease	0.000218	0.00124	CcSEcCtD
Trazodone—Syncope—Donepezil—Alzheimer's disease	0.000217	0.00124	CcSEcCtD
Trazodone—Flatulence—Memantine—Alzheimer's disease	0.000217	0.00124	CcSEcCtD
Trazodone—Tension—Memantine—Alzheimer's disease	0.000216	0.00123	CcSEcCtD
Trazodone—Dysgeusia—Memantine—Alzheimer's disease	0.000215	0.00123	CcSEcCtD
Trazodone—Fluphenazine—HTR6—Alzheimer's disease	0.000214	0.0423	CrCbGaD
Trazodone—Nervousness—Memantine—Alzheimer's disease	0.000214	0.00122	CcSEcCtD
Trazodone—Loss of consciousness—Donepezil—Alzheimer's disease	0.000213	0.00121	CcSEcCtD
Trazodone—HTR2A—central nervous system—Alzheimer's disease	0.000213	0.00399	CbGeAlD
Trazodone—Back pain—Memantine—Alzheimer's disease	0.000213	0.00121	CcSEcCtD
Trazodone—Flatulence—Rivastigmine—Alzheimer's disease	0.000212	0.00121	CcSEcCtD
Trazodone—Tension—Rivastigmine—Alzheimer's disease	0.000211	0.0012	CcSEcCtD
Trazodone—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000211	0.0012	CcSEcCtD
Trazodone—Feeling abnormal—Galantamine—Alzheimer's disease	0.00021	0.0012	CcSEcCtD
Trazodone—Hypertension—Donepezil—Alzheimer's disease	0.000209	0.00119	CcSEcCtD
Trazodone—Nervousness—Rivastigmine—Alzheimer's disease	0.000209	0.00119	CcSEcCtD
Trazodone—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000209	0.00119	CcSEcCtD
Trazodone—Back pain—Rivastigmine—Alzheimer's disease	0.000208	0.00119	CcSEcCtD
Trazodone—HTR2A—cerebellum—Alzheimer's disease	0.000208	0.0039	CbGeAlD
Trazodone—Vision blurred—Memantine—Alzheimer's disease	0.000207	0.00118	CcSEcCtD
Trazodone—Chest pain—Donepezil—Alzheimer's disease	0.000206	0.00118	CcSEcCtD
Trazodone—Arthralgia—Donepezil—Alzheimer's disease	0.000206	0.00118	CcSEcCtD
Trazodone—Myalgia—Donepezil—Alzheimer's disease	0.000206	0.00118	CcSEcCtD
Trazodone—Tremor—Memantine—Alzheimer's disease	0.000206	0.00118	CcSEcCtD
Trazodone—Anxiety—Donepezil—Alzheimer's disease	0.000206	0.00117	CcSEcCtD
Trazodone—CYP3A4—nervous system—Alzheimer's disease	0.000205	0.00384	CbGeAlD
Trazodone—Ill-defined disorder—Memantine—Alzheimer's disease	0.000204	0.00116	CcSEcCtD
Trazodone—Discomfort—Donepezil—Alzheimer's disease	0.000204	0.00116	CcSEcCtD
Trazodone—Anaemia—Memantine—Alzheimer's disease	0.000203	0.00116	CcSEcCtD
Trazodone—Vision blurred—Rivastigmine—Alzheimer's disease	0.000203	0.00116	CcSEcCtD
Trazodone—HRH1—brain—Alzheimer's disease	0.000202	0.00379	CbGeAlD
Trazodone—Agitation—Memantine—Alzheimer's disease	0.000202	0.00115	CcSEcCtD
Trazodone—Dry mouth—Donepezil—Alzheimer's disease	0.000202	0.00115	CcSEcCtD
Trazodone—Body temperature increased—Galantamine—Alzheimer's disease	0.000202	0.00115	CcSEcCtD
Trazodone—Abdominal pain—Galantamine—Alzheimer's disease	0.000202	0.00115	CcSEcCtD
Trazodone—Tremor—Rivastigmine—Alzheimer's disease	0.000202	0.00115	CcSEcCtD
Trazodone—CYP2D6—nervous system—Alzheimer's disease	0.000201	0.00378	CbGeAlD
Trazodone—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.0002	0.00114	CcSEcCtD
Trazodone—Confusional state—Donepezil—Alzheimer's disease	0.000199	0.00114	CcSEcCtD
Trazodone—Anaemia—Rivastigmine—Alzheimer's disease	0.000199	0.00113	CcSEcCtD
Trazodone—ADRA2A—brain—Alzheimer's disease	0.000199	0.00373	CbGeAlD
Trazodone—Malaise—Memantine—Alzheimer's disease	0.000198	0.00113	CcSEcCtD
Trazodone—Agitation—Rivastigmine—Alzheimer's disease	0.000198	0.00113	CcSEcCtD
Trazodone—Oedema—Donepezil—Alzheimer's disease	0.000198	0.00113	CcSEcCtD
Trazodone—Vertigo—Memantine—Alzheimer's disease	0.000198	0.00113	CcSEcCtD
Trazodone—Syncope—Memantine—Alzheimer's disease	0.000197	0.00113	CcSEcCtD
Trazodone—CYP3A4—central nervous system—Alzheimer's disease	0.000197	0.0037	CbGeAlD
Trazodone—Shock—Donepezil—Alzheimer's disease	0.000195	0.00111	CcSEcCtD
Trazodone—Palpitations—Memantine—Alzheimer's disease	0.000194	0.00111	CcSEcCtD
Trazodone—Malaise—Rivastigmine—Alzheimer's disease	0.000194	0.00111	CcSEcCtD
Trazodone—CYP2D6—central nervous system—Alzheimer's disease	0.000194	0.00364	CbGeAlD
Trazodone—Vertigo—Rivastigmine—Alzheimer's disease	0.000193	0.0011	CcSEcCtD
Trazodone—Loss of consciousness—Memantine—Alzheimer's disease	0.000193	0.0011	CcSEcCtD
Trazodone—Syncope—Rivastigmine—Alzheimer's disease	0.000193	0.0011	CcSEcCtD
Trazodone—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000191	0.00109	CcSEcCtD
Trazodone—Palpitations—Rivastigmine—Alzheimer's disease	0.00019	0.00108	CcSEcCtD
Trazodone—Hypertension—Memantine—Alzheimer's disease	0.00019	0.00108	CcSEcCtD
Trazodone—Trifluoperazine—CALM1—Alzheimer's disease	0.00019	0.0375	CrCbGaD
Trazodone—CYP2D6—cerebellum—Alzheimer's disease	0.00019	0.00355	CbGeAlD
Trazodone—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000189	0.00108	CcSEcCtD
Trazodone—Anorexia—Donepezil—Alzheimer's disease	0.000188	0.00108	CcSEcCtD
Trazodone—Hypersensitivity—Galantamine—Alzheimer's disease	0.000188	0.00107	CcSEcCtD
Trazodone—Perphenazine—CALM1—Alzheimer's disease	0.000188	0.0371	CrCbGaD
Trazodone—Myalgia—Memantine—Alzheimer's disease	0.000187	0.00107	CcSEcCtD
Trazodone—Chest pain—Memantine—Alzheimer's disease	0.000187	0.00107	CcSEcCtD
Trazodone—Arthralgia—Memantine—Alzheimer's disease	0.000187	0.00107	CcSEcCtD
Trazodone—Anxiety—Memantine—Alzheimer's disease	0.000187	0.00106	CcSEcCtD
Trazodone—Hypertension—Rivastigmine—Alzheimer's disease	0.000186	0.00106	CcSEcCtD
Trazodone—Discomfort—Memantine—Alzheimer's disease	0.000185	0.00106	CcSEcCtD
Trazodone—Hypotension—Donepezil—Alzheimer's disease	0.000185	0.00105	CcSEcCtD
Trazodone—Myalgia—Rivastigmine—Alzheimer's disease	0.000183	0.00104	CcSEcCtD
Trazodone—Arthralgia—Rivastigmine—Alzheimer's disease	0.000183	0.00104	CcSEcCtD
Trazodone—Chest pain—Rivastigmine—Alzheimer's disease	0.000183	0.00104	CcSEcCtD
Trazodone—Dry mouth—Memantine—Alzheimer's disease	0.000183	0.00104	CcSEcCtD
Trazodone—Asthenia—Galantamine—Alzheimer's disease	0.000183	0.00104	CcSEcCtD
Trazodone—Anxiety—Rivastigmine—Alzheimer's disease	0.000183	0.00104	CcSEcCtD
Trazodone—Confusional state—Memantine—Alzheimer's disease	0.000181	0.00103	CcSEcCtD
Trazodone—Discomfort—Rivastigmine—Alzheimer's disease	0.000181	0.00103	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00018	0.00103	CcSEcCtD
Trazodone—Oedema—Memantine—Alzheimer's disease	0.00018	0.00102	CcSEcCtD
Trazodone—Dry mouth—Rivastigmine—Alzheimer's disease	0.000179	0.00102	CcSEcCtD
Trazodone—Insomnia—Donepezil—Alzheimer's disease	0.000179	0.00102	CcSEcCtD
Trazodone—Paraesthesia—Donepezil—Alzheimer's disease	0.000178	0.00101	CcSEcCtD
Trazodone—Confusional state—Rivastigmine—Alzheimer's disease	0.000177	0.00101	CcSEcCtD
Trazodone—Shock—Memantine—Alzheimer's disease	0.000177	0.00101	CcSEcCtD
Trazodone—Dyspnoea—Donepezil—Alzheimer's disease	0.000176	0.00101	CcSEcCtD
Trazodone—Somnolence—Donepezil—Alzheimer's disease	0.000176	0.001	CcSEcCtD
Trazodone—Oedema—Rivastigmine—Alzheimer's disease	0.000176	0.001	CcSEcCtD
Trazodone—Tachycardia—Memantine—Alzheimer's disease	0.000175	0.000999	CcSEcCtD
Trazodone—Diarrhoea—Galantamine—Alzheimer's disease	0.000175	0.000996	CcSEcCtD
Trazodone—Hyperhidrosis—Memantine—Alzheimer's disease	0.000174	0.00099	CcSEcCtD
Trazodone—Shock—Rivastigmine—Alzheimer's disease	0.000173	0.000986	CcSEcCtD
Trazodone—Decreased appetite—Donepezil—Alzheimer's disease	0.000172	0.00098	CcSEcCtD
Trazodone—Tachycardia—Rivastigmine—Alzheimer's disease	0.000171	0.000978	CcSEcCtD
Trazodone—Trifluoperazine—HTR6—Alzheimer's disease	0.000171	0.0338	CrCbGaD
Trazodone—Anorexia—Memantine—Alzheimer's disease	0.000171	0.000976	CcSEcCtD
Trazodone—Fatigue—Donepezil—Alzheimer's disease	0.00017	0.000972	CcSEcCtD
Trazodone—Loxapine—HTR6—Alzheimer's disease	0.00017	0.0336	CrCbGaD
Trazodone—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00017	0.000968	CcSEcCtD
Trazodone—Perphenazine—HTR6—Alzheimer's disease	0.000169	0.0335	CrCbGaD
Trazodone—Pain—Donepezil—Alzheimer's disease	0.000169	0.000964	CcSEcCtD
Trazodone—Constipation—Donepezil—Alzheimer's disease	0.000169	0.000964	CcSEcCtD
Trazodone—HTR2A—brain—Alzheimer's disease	0.000169	0.00317	CbGeAlD
Trazodone—Dizziness—Galantamine—Alzheimer's disease	0.000169	0.000962	CcSEcCtD
Trazodone—Hypotension—Memantine—Alzheimer's disease	0.000168	0.000957	CcSEcCtD
Trazodone—Anorexia—Rivastigmine—Alzheimer's disease	0.000167	0.000955	CcSEcCtD
Trazodone—Quetiapine—HTR6—Alzheimer's disease	0.000166	0.0328	CrCbGaD
Trazodone—Hypotension—Rivastigmine—Alzheimer's disease	0.000164	0.000936	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000164	0.000933	CcSEcCtD
Trazodone—Feeling abnormal—Donepezil—Alzheimer's disease	0.000163	0.000929	CcSEcCtD
Trazodone—Insomnia—Memantine—Alzheimer's disease	0.000162	0.000926	CcSEcCtD
Trazodone—Vomiting—Galantamine—Alzheimer's disease	0.000162	0.000925	CcSEcCtD
Trazodone—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000162	0.000922	CcSEcCtD
Trazodone—Paraesthesia—Memantine—Alzheimer's disease	0.000161	0.000919	CcSEcCtD
Trazodone—Rash—Galantamine—Alzheimer's disease	0.000161	0.000918	CcSEcCtD
Trazodone—Dermatitis—Galantamine—Alzheimer's disease	0.000161	0.000917	CcSEcCtD
Trazodone—Dyspnoea—Memantine—Alzheimer's disease	0.00016	0.000913	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00016	0.000913	CcSEcCtD
Trazodone—Headache—Galantamine—Alzheimer's disease	0.00016	0.000912	CcSEcCtD
Trazodone—Somnolence—Memantine—Alzheimer's disease	0.00016	0.00091	CcSEcCtD
Trazodone—Insomnia—Rivastigmine—Alzheimer's disease	0.000159	0.000906	CcSEcCtD
Trazodone—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000158	0.0009	CcSEcCtD
Trazodone—Urticaria—Donepezil—Alzheimer's disease	0.000157	0.000896	CcSEcCtD
Trazodone—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000157	0.000893	CcSEcCtD
Trazodone—Abdominal pain—Donepezil—Alzheimer's disease	0.000156	0.000892	CcSEcCtD
Trazodone—Body temperature increased—Donepezil—Alzheimer's disease	0.000156	0.000892	CcSEcCtD
Trazodone—Somnolence—Rivastigmine—Alzheimer's disease	0.000156	0.000891	CcSEcCtD
Trazodone—Decreased appetite—Memantine—Alzheimer's disease	0.000156	0.00089	CcSEcCtD
Trazodone—Fatigue—Memantine—Alzheimer's disease	0.000155	0.000883	CcSEcCtD
Trazodone—CYP2D6—brain—Alzheimer's disease	0.000154	0.00289	CbGeAlD
Trazodone—Pain—Memantine—Alzheimer's disease	0.000154	0.000876	CcSEcCtD
Trazodone—Constipation—Memantine—Alzheimer's disease	0.000154	0.000876	CcSEcCtD
Trazodone—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000153	0.000871	CcSEcCtD
Trazodone—Nausea—Galantamine—Alzheimer's disease	0.000152	0.000864	CcSEcCtD
Trazodone—Fatigue—Rivastigmine—Alzheimer's disease	0.000151	0.000864	CcSEcCtD
Trazodone—Constipation—Rivastigmine—Alzheimer's disease	0.00015	0.000857	CcSEcCtD
Trazodone—Pain—Rivastigmine—Alzheimer's disease	0.00015	0.000857	CcSEcCtD
Trazodone—Feeling abnormal—Memantine—Alzheimer's disease	0.000148	0.000844	CcSEcCtD
Trazodone—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000147	0.000837	CcSEcCtD
Trazodone—Hypersensitivity—Donepezil—Alzheimer's disease	0.000146	0.000831	CcSEcCtD
Trazodone—ABCB1—nervous system—Alzheimer's disease	0.000145	0.00272	CbGeAlD
Trazodone—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000145	0.000825	CcSEcCtD
Trazodone—Hydroxyzine—CYP2D6—Alzheimer's disease	0.000144	0.0284	CrCbGaD
Trazodone—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000144	0.000819	CcSEcCtD
Trazodone—Clozapine—HTR6—Alzheimer's disease	0.000143	0.0282	CrCbGaD
Trazodone—Urticaria—Memantine—Alzheimer's disease	0.000143	0.000813	CcSEcCtD
Trazodone—Abdominal pain—Memantine—Alzheimer's disease	0.000142	0.000809	CcSEcCtD
Trazodone—Body temperature increased—Memantine—Alzheimer's disease	0.000142	0.000809	CcSEcCtD
Trazodone—Asthenia—Donepezil—Alzheimer's disease	0.000142	0.000809	CcSEcCtD
Trazodone—Pruritus—Donepezil—Alzheimer's disease	0.00014	0.000798	CcSEcCtD
Trazodone—Urticaria—Rivastigmine—Alzheimer's disease	0.00014	0.000796	CcSEcCtD
Trazodone—ABCB1—central nervous system—Alzheimer's disease	0.000139	0.00262	CbGeAlD
Trazodone—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000139	0.000792	CcSEcCtD
Trazodone—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000139	0.000792	CcSEcCtD
Trazodone—ABCB1—cerebellum—Alzheimer's disease	0.000136	0.00256	CbGeAlD
Trazodone—Diarrhoea—Donepezil—Alzheimer's disease	0.000135	0.000772	CcSEcCtD
Trazodone—Hypersensitivity—Memantine—Alzheimer's disease	0.000132	0.000754	CcSEcCtD
Trazodone—Dizziness—Donepezil—Alzheimer's disease	0.000131	0.000746	CcSEcCtD
Trazodone—Ziprasidone—SLC6A4—Alzheimer's disease	0.00013	0.0257	CrCbGaD
Trazodone—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000129	0.000738	CcSEcCtD
Trazodone—Asthenia—Memantine—Alzheimer's disease	0.000129	0.000735	CcSEcCtD
Trazodone—Pruritus—Memantine—Alzheimer's disease	0.000127	0.000724	CcSEcCtD
Trazodone—Asthenia—Rivastigmine—Alzheimer's disease	0.000126	0.000719	CcSEcCtD
Trazodone—Vomiting—Donepezil—Alzheimer's disease	0.000126	0.000717	CcSEcCtD
Trazodone—Rash—Donepezil—Alzheimer's disease	0.000125	0.000711	CcSEcCtD
Trazodone—Dermatitis—Donepezil—Alzheimer's disease	0.000125	0.00071	CcSEcCtD
Trazodone—Pruritus—Rivastigmine—Alzheimer's disease	0.000124	0.000709	CcSEcCtD
Trazodone—Headache—Donepezil—Alzheimer's disease	0.000124	0.000707	CcSEcCtD
Trazodone—Diarrhoea—Memantine—Alzheimer's disease	0.000123	0.000701	CcSEcCtD
Trazodone—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00012	0.000685	CcSEcCtD
Trazodone—Dizziness—Memantine—Alzheimer's disease	0.000119	0.000677	CcSEcCtD
Trazodone—Nausea—Donepezil—Alzheimer's disease	0.000117	0.00067	CcSEcCtD
Trazodone—Dizziness—Rivastigmine—Alzheimer's disease	0.000116	0.000662	CcSEcCtD
Trazodone—Vomiting—Memantine—Alzheimer's disease	0.000114	0.000651	CcSEcCtD
Trazodone—Rash—Memantine—Alzheimer's disease	0.000113	0.000646	CcSEcCtD
Trazodone—Dermatitis—Memantine—Alzheimer's disease	0.000113	0.000645	CcSEcCtD
Trazodone—Headache—Memantine—Alzheimer's disease	0.000112	0.000641	CcSEcCtD
Trazodone—Vomiting—Rivastigmine—Alzheimer's disease	0.000112	0.000637	CcSEcCtD
Trazodone—Rash—Rivastigmine—Alzheimer's disease	0.000111	0.000632	CcSEcCtD
Trazodone—ABCB1—brain—Alzheimer's disease	0.000111	0.00208	CbGeAlD
Trazodone—Dermatitis—Rivastigmine—Alzheimer's disease	0.000111	0.000631	CcSEcCtD
Trazodone—Headache—Rivastigmine—Alzheimer's disease	0.00011	0.000628	CcSEcCtD
Trazodone—Nefazodone—SLC6A4—Alzheimer's disease	0.000109	0.0216	CrCbGaD
Trazodone—Nausea—Memantine—Alzheimer's disease	0.000107	0.000608	CcSEcCtD
Trazodone—Nausea—Rivastigmine—Alzheimer's disease	0.000104	0.000595	CcSEcCtD
Trazodone—Aripiprazole—SLC6A4—Alzheimer's disease	0.000102	0.0201	CrCbGaD
Trazodone—Ziprasidone—HTR2A—Alzheimer's disease	0.0001	0.0198	CrCbGaD
Trazodone—Domperidone—CYP2D6—Alzheimer's disease	9.26e-05	0.0183	CrCbGaD
Trazodone—Ziprasidone—CYP2D6—Alzheimer's disease	9.15e-05	0.0181	CrCbGaD
Trazodone—Zuclopenthixol—HTR2A—Alzheimer's disease	8.46e-05	0.0167	CrCbGaD
Trazodone—Nefazodone—HTR2A—Alzheimer's disease	8.41e-05	0.0166	CrCbGaD
Trazodone—Aripiprazole—HTR2A—Alzheimer's disease	7.82e-05	0.0154	CrCbGaD
Trazodone—Zuclopenthixol—CYP2D6—Alzheimer's disease	7.74e-05	0.0153	CrCbGaD
Trazodone—Nefazodone—CYP2D6—Alzheimer's disease	7.69e-05	0.0152	CrCbGaD
Trazodone—Thioproperazine—HTR2A—Alzheimer's disease	7.41e-05	0.0146	CrCbGaD
Trazodone—Aripiprazole—CYP2D6—Alzheimer's disease	7.15e-05	0.0141	CrCbGaD
Trazodone—Loxapine—SLC6A4—Alzheimer's disease	6.52e-05	0.0129	CrCbGaD
Trazodone—Prochlorperazine—CYP2D6—Alzheimer's disease	6.37e-05	0.0126	CrCbGaD
Trazodone—Fluphenazine—HTR2A—Alzheimer's disease	6.3e-05	0.0124	CrCbGaD
Trazodone—Fluphenazine—CYP2D6—Alzheimer's disease	5.76e-05	0.0114	CrCbGaD
Trazodone—Trifluoperazine—HTR2A—Alzheimer's disease	5.04e-05	0.00995	CrCbGaD
Trazodone—Loxapine—HTR2A—Alzheimer's disease	5.01e-05	0.00989	CrCbGaD
Trazodone—Perphenazine—HTR2A—Alzheimer's disease	4.98e-05	0.00984	CrCbGaD
Trazodone—Quetiapine—HTR2A—Alzheimer's disease	4.89e-05	0.00965	CrCbGaD
Trazodone—Perphenazine—CYP2D6—Alzheimer's disease	4.56e-05	0.009	CrCbGaD
Trazodone—Quetiapine—CYP2D6—Alzheimer's disease	4.47e-05	0.00883	CrCbGaD
Trazodone—Clozapine—HTR2A—Alzheimer's disease	4.2e-05	0.0083	CrCbGaD
Trazodone—Clozapine—CYP2D6—Alzheimer's disease	3.85e-05	0.00759	CrCbGaD
Trazodone—ABCB1—Metabolism—PLCB1—Alzheimer's disease	5.09e-06	9.94e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MEF2C—Alzheimer's disease	5.09e-06	9.93e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IGF1—Alzheimer's disease	5.09e-06	9.93e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—BCHE—Alzheimer's disease	5.09e-06	9.92e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—INS—Alzheimer's disease	5.09e-06	9.92e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IGF2—Alzheimer's disease	5.05e-06	9.86e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—MTHFR—Alzheimer's disease	5.04e-06	9.84e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—LPL—Alzheimer's disease	5.04e-06	9.83e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CALM1—Alzheimer's disease	5.01e-06	9.78e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PRKCG—Alzheimer's disease	5.01e-06	9.77e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MEF2C—Alzheimer's disease	5e-06	9.75e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—APOE—Alzheimer's disease	5e-06	9.75e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—LEP—Alzheimer's disease	5e-06	9.75e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PRKCG—Alzheimer's disease	4.99e-06	9.74e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CALM1—Alzheimer's disease	4.99e-06	9.73e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—LEP—Alzheimer's disease	4.97e-06	9.7e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—APOE—Alzheimer's disease	4.97e-06	9.7e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CAV1—Alzheimer's disease	4.95e-06	9.66e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—ABCA1—Alzheimer's disease	4.94e-06	9.63e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CAV1—Alzheimer's disease	4.92e-06	9.61e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—TPI1—Alzheimer's disease	4.92e-06	9.6e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CHAT—Alzheimer's disease	4.92e-06	9.6e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PRKCG—Alzheimer's disease	4.9e-06	9.56e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IGF1R—Alzheimer's disease	4.89e-06	9.53e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—NGF—Alzheimer's disease	4.88e-06	9.51e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—NGF—Alzheimer's disease	4.87e-06	9.49e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	4.8e-06	9.36e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—NGF—Alzheimer's disease	4.77e-06	9.31e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—ESR1—Alzheimer's disease	4.77e-06	9.3e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—ESR1—Alzheimer's disease	4.74e-06	9.26e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CCR5—Alzheimer's disease	4.74e-06	9.25e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CCR5—Alzheimer's disease	4.73e-06	9.23e-05	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—TP53—Alzheimer's disease	4.72e-06	9.21e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—MAOB—Alzheimer's disease	4.72e-06	9.21e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—CALM1—Alzheimer's disease	4.71e-06	9.19e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—F2—Alzheimer's disease	4.71e-06	9.19e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—APOE—Alzheimer's disease	4.7e-06	9.16e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—F2—Alzheimer's disease	4.69e-06	9.14e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—LPL—Alzheimer's disease	4.68e-06	9.14e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—CAV1—Alzheimer's disease	4.65e-06	9.08e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	4.65e-06	9.07e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CCR5—Alzheimer's disease	4.64e-06	9.06e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MEF2C—Alzheimer's disease	4.64e-06	9.06e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—HTR2A—Alzheimer's disease	4.63e-06	9.04e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	4.62e-06	9.02e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—NOS3—Alzheimer's disease	4.61e-06	9e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—NOTCH1—Alzheimer's disease	4.61e-06	8.99e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—NOTCH1—Alzheimer's disease	4.59e-06	8.95e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PRKCG—Alzheimer's disease	4.55e-06	8.88e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—HTR2A—Alzheimer's disease	4.55e-06	8.87e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	4.54e-06	8.86e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—NOS3—Alzheimer's disease	4.46e-06	8.7e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—NGF—Alzheimer's disease	4.44e-06	8.65e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—A2M—Alzheimer's disease	4.39e-06	8.56e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CALM1—Alzheimer's disease	4.33e-06	8.45e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—GSK3B—Alzheimer's disease	4.33e-06	8.44e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CALM1—Alzheimer's disease	4.32e-06	8.43e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—CALM1—Alzheimer's disease	4.32e-06	8.42e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—APOE—Alzheimer's disease	4.32e-06	8.42e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—LEP—Alzheimer's disease	4.32e-06	8.42e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCR5—Alzheimer's disease	4.32e-06	8.42e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—LEP—Alzheimer's disease	4.31e-06	8.4e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—APOE—Alzheimer's disease	4.31e-06	8.4e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—GSK3B—Alzheimer's disease	4.3e-06	8.4e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—APOE—Alzheimer's disease	4.3e-06	8.39e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CREB1—Alzheimer's disease	4.29e-06	8.37e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CAV1—Alzheimer's disease	4.28e-06	8.34e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CREB1—Alzheimer's disease	4.27e-06	8.33e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—INS—Alzheimer's disease	4.27e-06	8.33e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CAV1—Alzheimer's disease	4.27e-06	8.32e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—CAV1—Alzheimer's disease	4.26e-06	8.32e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	4.25e-06	8.3e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—INS—Alzheimer's disease	4.25e-06	8.28e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CALM1—Alzheimer's disease	4.24e-06	8.27e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—HMOX1—Alzheimer's disease	4.24e-06	8.26e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—APOE—Alzheimer's disease	4.23e-06	8.24e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—LEP—Alzheimer's disease	4.23e-06	8.24e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—HTR2A—Alzheimer's disease	4.22e-06	8.24e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CCL2—Alzheimer's disease	4.2e-06	8.19e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CAV1—Alzheimer's disease	4.19e-06	8.17e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CCL2—Alzheimer's disease	4.18e-06	8.15e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IGF1—Alzheimer's disease	4.13e-06	8.05e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—ESR1—Alzheimer's disease	4.12e-06	8.04e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—ESR1—Alzheimer's disease	4.11e-06	8.02e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IGF1—Alzheimer's disease	4.11e-06	8.01e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PPARG—Alzheimer's disease	4.09e-06	7.98e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—PTGS2—Alzheimer's disease	4.08e-06	7.96e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—F2—Alzheimer's disease	4.07e-06	7.94e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—F2—Alzheimer's disease	4.06e-06	7.92e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—ESR1—Alzheimer's disease	4.03e-06	7.87e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—INS—Alzheimer's disease	4.01e-06	7.83e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	4.01e-06	7.82e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	3.99e-06	7.79e-05	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	3.99e-06	7.78e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—F2—Alzheimer's disease	3.98e-06	7.77e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—NOTCH1—Alzheimer's disease	3.98e-06	7.77e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—NOTCH1—Alzheimer's disease	3.97e-06	7.75e-05	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—AKT1—Alzheimer's disease	3.95e-06	7.71e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	3.94e-06	7.69e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	3.93e-06	7.66e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	3.93e-06	7.66e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CASP3—Alzheimer's disease	3.92e-06	7.64e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	3.9e-06	7.61e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—IL6—Alzheimer's disease	3.89e-06	7.59e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	3.89e-06	7.59e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—LPL—Alzheimer's disease	3.87e-06	7.56e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ACHE—Alzheimer's disease	3.82e-06	7.45e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	3.77e-06	7.36e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	3.75e-06	7.31e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PPARG—Alzheimer's disease	3.75e-06	7.31e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	3.74e-06	7.3e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	3.74e-06	7.29e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—GSK3B—Alzheimer's disease	3.73e-06	7.28e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	3.72e-06	7.26e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	3.71e-06	7.23e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	3.7e-06	7.22e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CREB1—Alzheimer's disease	3.7e-06	7.22e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—INS—Alzheimer's disease	3.69e-06	7.19e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—INS—Alzheimer's disease	3.68e-06	7.18e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—INS—Alzheimer's disease	3.68e-06	7.17e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	3.66e-06	7.14e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—LPL—Alzheimer's disease	3.65e-06	7.12e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	3.63e-06	7.08e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	3.63e-06	7.08e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	3.62e-06	7.07e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CCL2—Alzheimer's disease	3.62e-06	7.06e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	3.61e-06	7.04e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MAPK8—Alzheimer's disease	3.6e-06	7.02e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—AKT1—Alzheimer's disease	3.59e-06	7.01e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	3.58e-06	6.98e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ENO1—Alzheimer's disease	3.58e-06	6.98e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	3.57e-06	6.96e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	3.56e-06	6.94e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	3.55e-06	6.93e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—NOS3—Alzheimer's disease	3.52e-06	6.86e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	3.51e-06	6.84e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	3.49e-06	6.81e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—MTHFR—Alzheimer's disease	3.49e-06	6.8e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	3.4e-06	6.63e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	3.37e-06	6.58e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	3.35e-06	6.54e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—BCHE—Alzheimer's disease	3.33e-06	6.49e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—VEGFA—Alzheimer's disease	3.32e-06	6.49e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	3.3e-06	6.44e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	3.29e-06	6.41e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CALM1—Alzheimer's disease	3.26e-06	6.36e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—APOE—Alzheimer's disease	3.25e-06	6.33e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	3.24e-06	6.33e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	3.23e-06	6.31e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	3.23e-06	6.29e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—NOS3—Alzheimer's disease	3.22e-06	6.29e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	3.22e-06	6.28e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CAV1—Alzheimer's disease	3.22e-06	6.28e-05	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	3.21e-06	6.26e-05	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	3.19e-06	6.22e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	3.18e-06	6.2e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	3.17e-06	6.18e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	3.16e-06	6.17e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	3.16e-06	6.16e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	3.14e-06	6.13e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	3.14e-06	6.12e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CALM1—Alzheimer's disease	3.07e-06	5.99e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—APOE—Alzheimer's disease	3.06e-06	5.97e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TGFB1—Alzheimer's disease	3.05e-06	5.95e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	3.04e-06	5.93e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CAV1—Alzheimer's disease	3.03e-06	5.91e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	2.95e-06	5.75e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	2.94e-06	5.74e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	2.92e-06	5.7e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	2.91e-06	5.68e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	2.91e-06	5.67e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	2.9e-06	5.65e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PPARG—Alzheimer's disease	2.83e-06	5.52e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—INS—Alzheimer's disease	2.77e-06	5.41e-05	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.77e-06	5.4e-05	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.76e-06	5.39e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	2.74e-06	5.35e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	2.74e-06	5.34e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	2.73e-06	5.32e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	2.72e-06	5.31e-05	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.71e-06	5.29e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	2.7e-06	5.26e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	2.69e-06	5.24e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	2.68e-06	5.23e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	2.67e-06	5.21e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PPARG—Alzheimer's disease	2.66e-06	5.2e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	2.62e-06	5.11e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—INS—Alzheimer's disease	2.61e-06	5.1e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	2.61e-06	5.09e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	2.52e-06	4.92e-05	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.52e-06	4.92e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	2.52e-06	4.91e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	2.52e-06	4.91e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TP53—Alzheimer's disease	2.51e-06	4.9e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	2.51e-06	4.9e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	2.5e-06	4.87e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	2.48e-06	4.84e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	2.47e-06	4.83e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	2.47e-06	4.82e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	2.46e-06	4.81e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	2.46e-06	4.8e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—NOS3—Alzheimer's disease	2.43e-06	4.75e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—LPL—Alzheimer's disease	2.39e-06	4.66e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	2.33e-06	4.54e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	2.32e-06	4.53e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IL6—Alzheimer's disease	2.3e-06	4.49e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	2.3e-06	4.48e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—NOS3—Alzheimer's disease	2.29e-06	4.47e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	2.29e-06	4.47e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	2.28e-06	4.45e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PTGS2—Alzheimer's disease	2.22e-06	4.34e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.15e-06	4.19e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	2.14e-06	4.17e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	2.13e-06	4.16e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—AKT1—Alzheimer's disease	2.12e-06	4.14e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	2.12e-06	4.13e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.1e-06	4.09e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	2.09e-06	4.08e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—AKT1—Alzheimer's disease	2.05e-06	4e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	2.04e-06	3.97e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	2.03e-06	3.95e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.01e-06	3.92e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—APOE—Alzheimer's disease	2e-06	3.9e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.98e-06	3.87e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.94e-06	3.79e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	1.86e-06	3.64e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	1.86e-06	3.62e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	1.76e-06	3.43e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TP53—Alzheimer's disease	1.76e-06	3.43e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.74e-06	3.4e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	1.72e-06	3.36e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	1.72e-06	3.36e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	1.71e-06	3.34e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—INS—Alzheimer's disease	1.71e-06	3.33e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—AKT1—Alzheimer's disease	1.62e-06	3.15e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	1.61e-06	3.14e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL6—Alzheimer's disease	1.61e-06	3.14e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	1.6e-06	3.12e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	1.58e-06	3.08e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.5e-06	2.92e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	1.49e-06	2.9e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	1.48e-06	2.89e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—AKT1—Alzheimer's disease	1.48e-06	2.89e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	1.47e-06	2.86e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	1.46e-06	2.84e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.37e-06	2.67e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	1.35e-06	2.64e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—AKT1—Alzheimer's disease	1.12e-06	2.18e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.05e-06	2.06e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—AKT1—Alzheimer's disease	6.89e-07	1.34e-05	CbGpPWpGaD
